<!DOCTYPE html>
<!--[if IE 9]><html lang="en-US" class="no-js ie-9"> <![endif]-->
<!--[if gt IE 9]><!--> <html lang="en-US" class="no-js"><!--<![endif]-->
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=0">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<title>Quality Management System Regulation (QMSR) &ndash; Harmonizing the Quality System Regulation (QSR) with ISO 13485:2016 | MoFo Life Sciences</title>
<meta name="description" itemprop="description" content>
<meta name="description" itemprop="keywords" content>
<link rel="canonical" href="https://lifesciences.mofo.com/topics/quality-management-system-regulation-qmsr--harmonizing-the-quality-system-regulation-qsr-with-iso-134852016.html">
<link rel="stylesheet" id="validate-engine-css-css" href="css/blog-validationEngine.jquery.css" type="text/css" media="all">
<link rel="stylesheet" id="fontello-css" href="css/blog-embedded.css" type="text/css" media="all">
<link rel="stylesheet" id="mofo-fonts-css" href="css/blog-fonts.css" type="text/css" media="all">
<link rel="stylesheet" id="child-normalize-css" href="css/blog-normalize.css" type="text/css" media="all">
<link rel="stylesheet" id="child-foundation-css" href="css/blog-foundation.css" type="text/css" media="all">
<link rel="stylesheet" id="child-style-css" href="css/blog-style.css" type="text/css" media="all">
<link rel="stylesheet" id="child-jetpack-css" href="css/blog-jetpack.css" type="text/css" media="all">
<link rel="stylesheet" href="css/blog-custom-style.css" type="text/css" media="all">
<link rel="stylesheet" href="css/blog-print.css" type="text/css" media="all">
<link rel="stylesheet" href="css/blog-simple-nav.css" type="text/css" media="all">
<link rel="shortcut icon" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png" type="image/icon">
<link rel="shortcut icon" type="image/vnd.microsoft.icon" href="favicon.ico">
<link rel="icon" href="favicon.ico" type="image/icon">
<link rel="apple-touch-icon" type="image/png" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png"><!-- iPhone -->
<link rel="apple-touch-icon" type="image/png" sizes="72x72" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png"><!-- iPad -->
<link rel="apple-touch-icon" type="image/png" sizes="114x114" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png"><!-- iPhone4 -->
<link rel="stylesheet" href="css/jquery-ui.css">


    <!-- Google Tag Manager -->
    <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
    new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
    j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
    'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
    })(window,document,'script','dataLayer','GTM-T8Z9VLF');</script>
    <!-- End Google Tag Manager -->


<script defer src="js/all.js" crossorigin="anonymous"></script>

<!-- Jetpack Open Graph Tags -->
<meta property="og:type" content="website">
<meta property="og:title" content="Quality Management System Regulation (QMSR) â€“ Harmonizing the Quality System Regulation (QSR) with ISO 13485:2016">


																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															<meta property="og:description" content="Jianyuan+%28Yuan%29+Hua%2C+FDA+Regulatory+and+Compliance+Associate+in+New+York%2C+contributed+to+the+drafting+of+this+post.%0A%0AThe+U.S.+Food+and+Drug+Administration+%28FDA%29+issued+the+much-anticipated+proposed+rule+%26ldquo%3BMedical+Devices%3A+Quality+System+Regulation+Amendments%2C%26rdquo%3B+which+will+harmonize+the+current+Quality+System+Regulation+%28QSR%3B">
<meta property="og:url" content="https://lifesciences.mofo.com/topics/quality-management-system-regulation-qmsr--harmonizing-the-quality-system-regulation-qsr-with-iso-134852016.html">
<meta property="og:site_name" content="MoFo Life Sciences">
<meta property="og:image" content="https://media2.mofo.com/images/mofolifesciences-medical-devices.jpg">
<meta property="og:locale" content="en_US">



<style>
.svg-inline--fa {

    /*height: .8em;*/

    }
.svg-inline--fa {
    width: .475em;
}
 .sd-content a.nc-facebook-circled{
     color: #3b5998;
     font-size: 30px;
     }
     .sd-content a.nc-linkedin-circled{
     color: #0077b5;
     font-size: 30px;
     }
     .sd-content a.nc-twitter-circled{
     color: #00acee;
     font-size: 30px;
     }
     .sd-content a.nc-fa-envelope-square{
     color: #034193 ;
     font-size: 30px;
     }  
     .sd-content a.nc-fa-print{
     color: #000 ;
     font-size: 30px;
     }                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
     .sd-content a hover {
     }
     .sd-content i {
      margin: -4px;
     }
     #searchsubmit {
      font-size: 1em;
      border-radius: 3px;
      font-family: 'Oswald';
      text-transform: uppercase;
      letter-spacing: 2px;
      border-style: solid;
      border-width: 0;
      font-weight: 500;
    }
</style>

<meta name="google-site-verification" content="OD6S3RPM-cQOknAs1uXmBRvRJyh28rwkOoqdes47ZUE">
</head>
<body class="single single-post postid-576269231 single-format-standard full-width custom-background-empty">
    <!-- Google Tag Manager (noscript) -->
    <noscript>
      <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-T8Z9VLF" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <!-- End Google Tag Manager (noscript) -->
    <script type="text/javascript"> 
<!-- 
var bb=new Image();var _ti=910;var _q="";var na=(navigator.appName=="Netscape");var ns=(navigator.appName.substring(0,9)=="Microsoft");var _qDate=new Date();var _r=(document.referrer.indexOf(getdomain(location))>-1?"":document.referrer);_q+="&5="+parseInt(_qDate.getTimezoneOffset());_q+="&35="+parseInt(_qDate.toString().indexOf("aylight")>-1?1:0);_q+="&6=576269231";_q+="&7=3262841";_q+="&8="+encodeURIComponent(document.location);_q+="&9="+encodeURIComponent(_r);_q+="&10="+encodeURIComponent(document.title);_q+="&11="+encodeURIComponent(navigator.userAgent);_q+="&12="+encodeURIComponent((na?navigator.language:navigator.userLanguage));_q+="&13="+((navigator.javaEnabled()?'1':'0'));if(document.cookie.indexOf("cc")==-1)document.cookie="cc=t;";_q+="&15="+((document.cookie.indexOf("cc")==-1)?"0":"1");_q+="&16="+encodeURIComponent((screen.width+'x'+screen.height));_q+="&17="+encodeURIComponent(((ns)?screen.colorDepth:screen.pixelDepth));_q+="&18="+encodeURIComponent(Math.random());_q+="&19="+_ti;bb.src="https://s.clickability.com/s?"+_q;
function setonclicks(a,b){var i=0;var retval=true;while(document.links[i]!=a){i++;}if(b.li[i])retval=b.li[i].oldonclick();bye(a);return retval;}
function newonld(){if(hasonload)oldonld();lnks=new Object();var sze=document.links.length;lnks.li=new Array(sze);for (var i=0; i<sze; i++){if(document.links[i].onclick){lnks.li[i]=document.links[i];lnks.li[i].oldonclick=document.links[i].onclick;}eval("document.links[i].onclick=function(){return setonclicks(this,lnks);}");}}function bye(a){if(a.href.toLowerCase().indexOf('http')!=0)return true;if(getdomain(location)==getdomain(a))return true;if(a.href.toLowerCase().indexOf('http')!=0)return true;var _qc="https://s.clickability.com/s?19=912";_qc+="&6=576269231";_qc+="&7=3262841";_qc+="&18="+encodeURIComponent(Math.random());_qc+="&100="+a.href;_qc+="&101="+encodeURIComponent(a.text);var cc=new Image();if(na){cc.src=_qc;pc(100);}else cc.src=_qc;return true;}function pc(a){d = new Date(); while (1){m =new Date(); df = m-d;if( df > a ) {break;}}}function getdomain(a){var i=a.host.indexOf(":");return (i>=0)?a.host.substring(0,i):a.host;}if(self['setupalready']){var dosetup = false;alert('There are two $imware.tracker calls on this page. Please alert Client Services');}else{var dosetup = true;var hasonload=false;}if(dosetup && ((window.screen)||((new Array()).toSource)||((new Array()).shift&&ns))&&(navigator.userAgent.indexOf('Mac')<0)){if(window.onload){oldonld=window.onload;hasonload=true;}window.onload=newonld;var setupalready = true;}//-->
</script><noscript>
<img alt="Clickability tracking pixel" width="1" height="1" src="https://s.clickability.com/s?19=990&amp;14=0&amp;6=576269231&amp;7=3262841&amp;25=0&amp;18=0.6643193294132769">
</noscript>

<div class="main-body-container" data-equalizer>    
<div class="nav_container">
	<a class="skip-link screen-reader-text" href="#content">Skip to content</a>  
        <div class="nav_wrap row ">
        	<div> <!-- add sticky here if needed -->
        	  <div>
                    <nav class="top-bar" data-topbar data-options="scrolltop:false;mobile_show_parent_link:false;">                  
                        <ul class="title-area">
	                        <li class="mofo-logo">
			                    <a href="https://www.mofo.com" title="Morrison & Foerster" target="_blank">
						<img src="https://media2.mofo.com/images/morrison-foerster-blog-logo.png" alt="logo">
			                    </a>
			                </li>
                            <li class="name">
                                <div class="header-title">
                                	<a href="index.html" title="MoFo Life Sciences" rel="home">
                                	                                	MoFo Life Sciences
                                	                                	</a>
                                </div>
                                                                <div class="header-subtitle">
                               		<span class="pms-7702c">Because No One is Immune to the Law</span>
                                </div>
                                                            </li>							
                            <!-- Remove the class "menu-icon" to get rid of menu icon. Take out "Menu" to just have icon alone -->
                                                    </ul>
</nav>
</div><!-- contain-to-grid sticky -->                
</div><!-- .row -->
</div>        
</div>
<!-- end .nav_container -->  


<div class="topnav" id="myTopnav">

<a href="index.html">Home</a>



<div class="divider"></div>
<div class="dropdown">

    <button class="dropbtn active">Topics 
     <i class="fa fa-caret-down"></i>
    </button>
    <div class="dropdown-content">

	
		 	<a href="topics_20.html">AI + Robotics</a>
		 	<a href="topics_5.html">Agtech</a>
		 	<a href="topics.html">Announcements</a>
		 	<a href="topics_2.html">Antitrust</a>
		 	<a href="topics_13.html">Asia</a>
		 	<a href="topics_9.html">Bioinformatics</a>
		 	<a href="topics_27.html">Biotech</a>
		 	<a href="topics_30.html">Blockchain</a>
		 	<a href="topics_6.html">CFIUS</a>
		 	<a href="topics_4.html">COVID-19</a>
		 	<a href="topics_16.html">Corporate + Venture Capital</a>
		 	<a href="topics_10.html">Data Analytics</a>
		 	<a href="topics_11.html">Digital Health</a>
		 	<a href="topics_23.html">Employment</a>
		 	<a href="topics_31.html">European Union</a>
		 	<a href="topics_18.html">FDA</a>
		 	<a href="topics_12.html">Financing</a>
		 	<a href="topics_29.html">Global</a>
		 	<a href="topics_21.html">Healthcare</a>
		 	<a href="topics_24.html">Intellectual Property</a>
		 	<a href="topics_3.html">Licensing + Commercial</a>
		 	<a href="topics_15.html">Litigation</a>
		 	<a href="topics_25.html">Medical Devices + Diagnostics</a>
		 	<a href="topics_17.html">Pharma</a>
		 	<a href="topics_19.html">Privacy + Data Security</a>
		 	<a href="topics_14.html">Product Liability + Class Action</a>
		 	<a href="topics_7.html">Rare Disease</a>
		 	<a href="topics_1.html">Regulatory</a>
		 	<a href="topics_26.html">Startup</a>
		 	<a href="topics_28.html">United Kingdom</a>
		 	<a href="topics_22.html">United States</a>
    </div>
  </div> 


<div class="divider"></div>
<a href="editors.html" class>Editors</a>


<div class="divider"></div>
<a href="about.html" class>About</a>


<div class="divider"></div>
<a href="javascript:void(0);" onclick="openSubscribeModal()" class>Subscribe</a>




<a href="javascript:void(0);" style="font-size:15px;" class="icon" onclick="myFunction()">&#9776;</a>
</div>
    
    
    
    


<script>
function printPage() {
  window.print();
}
</script>



<div class="content_container">
    <section class="content_wrap row" role="document">
        <div id="content" class="medium-8 large-8 columns" role="main">
            <article id="post-576269231" class="post-576269231 post type-post status-publish format-standard has-post-thumbnail hentry category-foreign-corrupt-practices-act">
                <header class="entry-header">
                    <div class="row blog-header">
                        <div class="columns medium-7 rockwell pms-7702c">
                            <em>March 7, 2022</em>
                            - <a href="topics_18.html" rel="category tag">FDA</a>, <a href="topics_21.html" rel="category tag">Healthcare</a>, <a href="topics_25.html" rel="category tag">Medical Devices + Diagnostics</a>, <a href="topics_1.html" rel="category tag">Regulatory</a>, <a href="topics_22.html" rel="category tag">United States</a>
                        </div>
                        <div class="columns medium-5 social-jet">
                            <div class="sharedaddy sd-sharing-enabled">
                                <div class="robots-nocontent sd-block sd-social sd-social-icon sd-sharing">
                                    <h3 class="sd-title">Share This</h3>
                                            <div class="sd-content">
                                                <a title="Share on Facebook" class="nc-facebook-circled" href="unsupportedbrowser.html" target="_blank" onclick="javascript:window.open(this.href, '', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=350,width=600');return false;" rel="nofollow">
                                                    <i class="fab fa-facebook-square"></i>
                                                                                                    </a>
                                                <a href="https://www.linkedin.com/shareArticle?mini=true&amp;url=https://lifesciences.mofo.com/topics/quality-management-system-regulation-qmsr--harmonizing-the-quality-system-regulation-qsr-with-iso-134852016.html&amp;title=Quality Management System Regulation (QMSR) â€“ Harmonizing the Quality System Regulation (QSR) with ISO 13485:2016&amp;summary=Jianyuan (Yuan) Hua, FDA Regulatory and Compliance Associate in New York, contributed to the drafting of this post.

The U.S. Food and Drug Administration (FDA) issued the much-anticipated proposed rule Medical Devices: Quality System Regulation Amendments, which will harmonize the current Quality System Regulation (QSR;&amp;source=LinkedIn" onclick="javascript:window.open(this.href, '', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=350,width=600');return false;" rel="nofollow" class="nc-linkedin-circled" target="_blank" title="Share on LinkedIn">
                                                    <i class="fab fa-linkedin"></i>
                                                                                                    </a>
                                                <a href="share_131.html" onclick="javascript:window.open(this.href, '', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=350,width=600');return false;" rel="nofollow" target="_blank" class="nc-twitter-circled" title="Share on Twitter">
                                                    <i class="fab fa-twitter-square"></i>
                                                                                                    </a>
                                                <a href="mailto:recipient@domain.com?subject=MoFo Life Sciences&amp;body=Quality Management System Regulation (QMSR) â€“ Harmonizing the Quality System Regulation (QSR) with ISO 13485:2016 - https://lifesciences.mofo.com/topics/quality-management-system-regulation-qmsr--harmonizing-the-quality-system-regulation-qsr-with-iso-134852016.html" rel="nofollow" class="nc-fa-envelope-square" title="Email this page">
                                                  <i class="fas fa-envelope-square"></i>
                                                </a>
                                                <a href="#" onclick="printPage()" rel="nofollow" class="nc-fa-print" title="Print this page">
                                                  <i class="fas fa-print"></i>
                                                </a>
                                            </div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <h1 class="entry-title">
                        Quality Management System Regulation (QMSR) â€“ Harmonizing the Quality System Regulation (QSR) with ISO 13485:2016</h1>
                </header>
                <!-- .entry-header -->
                <div class="entry-meta">
                    <div class="blog-author-meta subheader">			
                                                

                                                By: <a href="https://www.mofo.com/people/brigid-bondoc.html" target="new">Brigid DeCoursey Bondoc</a> and <a href="https://www.mofo.com/people/rachel-park.html" target="new">Rachel Park</a>
                                                                    </div>
                </div>
                <div class="entry-content">
                                    <img width="300" class="alignright" src="https://media2.mofo.com/images/mofolifesciences-medical-devices.jpg">
                                        <p><i>Jianyuan (Yuan) Hua, FDA Regulatory and Compliance Associate in New York, contributed to the drafting of this post.</i></p>
<p style="text-align: left;" class="Default">The U.S. Food and Drug Administration (FDA) issued the much-anticipated <a target="_blank" href="https://www.federalregister.gov/documents/2022/02/23/2022-03227/medical-devices-quality-system-regulation-amendments">proposed rule</a> &ldquo;Medical Devices: Quality System Regulation Amendments,&rdquo; which will harmonize the current Quality System Regulation (QSR; 21 CFR Part 820) with the international standard specific for medical device quality management systems set by the International Organization for Standardization, ISO 13485:2016. &nbsp;QSR has been the core regulation for device manufacturing in the United States since its implementation over 20 years ago. &nbsp;Medical device establishments have come to have an increasingly international presence, necessitating significant efforts to comply with different requirements.&nbsp; In order to reduce compliance costs for industry and harmonize domestic and international requirements, FDA first signaled its <a target="_blank" href="https://www.fda.gov/media/123488/download">intent</a> to align its QSR with the ISO 13485:2016 in December 2018, and estimated that a proposed rule would be issued in fall 2019.&nbsp; After delays likely caused by FDA&rsquo;s shift in priorities to focus on the COVID-19 response, the agency finally published the proposed rule last month. &nbsp;The long-awaited and long-delayed proposed rule, if finalized, will rename 21 CFR Part 820 as &ldquo;Quality Management System Regulation&rdquo; (QMSR), and will harmonize the U.S. good manufacturing practices with international standards. &nbsp;The proposal projects to save medical device establishments hundreds of millions of dollars in compliance costs.&nbsp;</p>
<p style="text-align: left;" class="Default">Many expected that FDA would rewrite QSR in order to align the U.S. regulatory framework with the ISO standard.&nbsp; To the surprise of many, FDA performed a gap analysis and now proposes to incorporate ISO 13485 by reference rather than re-writing the regulation in its entirety. &nbsp;ISO 13485 was first introduced in 1996, around the same time when FDA significantly revised Part 820, establishing the current QS regulation.&nbsp; ISO 13485 went through many revisions since its first issuance, and its most current version has become more closely aligned with the requirements in part 820. &nbsp;Notably, the 2016 updates to ISO 13485 included several requirements mandated by FDA under its QSR, such as document control and records management, particularly as both relate to protecting confidential information.&nbsp; This alignment, as well as the agency&rsquo;s commitment to global regulatory harmonization of medical device regulatory processes, prompted FDA to further explore incorporating the Quality Management System (QMS) requirements of ISO 13485:2016 into Part 820. &nbsp;However, this &ldquo;incorporation by reference&rdquo; approach only applies to the current 2016 version of ISO 13485 and &ldquo;[a]ny future revisions to this standard would need to be evaluated&rdquo; before being incorporated. &nbsp;</p>
<p style="text-align: left;">As before, the proposed rule will only apply to finished devices, although FDA reiterates that it has the legal authority to apply the quality system requirements to manufacturers of components or parts of finished devices when needed. &nbsp;The proposed QMSR, a nine-page document, is a &ldquo;gap regulation&rdquo; that is intended to be read in conjunction with ISO 13485. &nbsp;Specifically, the proposed rule addresses FDA-specific requirements by adding necessary requirements and definitions that are absent from ISO 13485 and removing redundant or inconsistent regulations from Part 820.&nbsp; For example, the proposed rule removed the term &ldquo;device master record&rdquo; (DMR) because (1) the concept is covered by ISO 13485&rsquo;s Clause 4.2.3 on medical device files (MDF) and (2) under the QSR, the DMR is part of the design history file, which is inconsistent with the ISO standard. &nbsp;Below are some key sections of the new proposed rule.</p>
<p style="text-align: left;"><b>Inspection</b>.<b> &nbsp;</b>The proposed rule does not impact FDA&rsquo;s authority to conduct inspections under section 704 of the Food Drug and Cosmetic Act (&ldquo;FD&amp;C Act&rdquo;) (21 U.S.C. &sect; 374). &nbsp;However, FDA intends to replace its current inspection approach for medical devices, the Quality System Inspection Technique (QSIT), with an inspection approach that will be consistent with the requirements of the proposed Part 820 as finalized.&nbsp; Similar to the current QSIT inspection approach, these inspections would involve the collection of information to support observations noted during the inspection and included on FDA Form 483, as appropriate and necessary. &nbsp;FDA inspections will not result in the issuance of certificates of conformance to ISO 13485, nor is FDA developing a certification program for ISO 13485 or the revised Part 820. &nbsp;In addition, manufacturers with a certificate of conformance to ISO 13485 are not exempt from FDA inspections. &nbsp;Firms will need to participate in the Medical Device Single Audit Program (MDSAP) to avoid routine FDA inspections.</p>
<p style="text-align: left;"><b>Supplementary Provisions</b>.&nbsp; To fill the gap with ISO 13485, the proposed rule seeks to add <br> (1) control of records (proposed section&thinsp;820.35) and (2) device labeling and packaging controls (proposed section&thinsp;820.45) to ensure consistency and alignment with other requirements in the FD&amp;C Act and its implementing regulations. &nbsp;</p>
<p style="text-align: left;">For<b> control of records</b>, the agency plans to add the following requirements:&nbsp;</p>
<ul style="text-align: left;">
<li>First, signature and date requirements will be required for records subject to Clause 4.2.5 of ISO 13485 (Control of Records).&nbsp; </li>
<li>Second, information required by Part 803 (Medical Device Reporting) must be captured on certain records of complaints and servicing activities.&nbsp; </li>
<li>Third, firms need to document in their records the Unique Device Identification (UDI) for each medical device or batch of medical devices in accordance with Part 830.&nbsp; </li>
<li>Fourth, FDA proposes to retain the clarification from current Part 820 (section 820.180) about confidentiality of records FDA receives to remind firms that FDA protects such records in accordance with Part 20.</li>
</ul>
<p style="text-align: left;">For<b> device labeling and packaging</b>, ISO 13485 only states that &ldquo;defined operations for labeling and packaging shall be implemented&rdquo; without specifically addressing the inspection of labeling by the manufacturer. &nbsp;Given that many device recalls are related to labeling and packaging, FDA proposes to supplement the ISO standard by retaining requirements from the current Part 820 (i.e., Subpart K). &nbsp;If finalized, regulated industry must meet the requirements in ISO 13485 7.5.1 (Control of Production and Service) and the proposed section&thinsp;820.45.</p>
<p style="text-align: left;"><b>Table 1&mdash;High-Level Summary of 21 CFR Part 820 Proposed Rule Differences and Additions</b></p>
<table style="text-align: left;" border="1" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td width="165" valign="top">
<p><b>Current part 820&thinsp;</b></p>
</td>
<td width="229" valign="top">
<p><b>ISO 13485 requirements&thinsp;</b></p>
</td>
<td valign="top">
<p><b>Proposed rule</b></p>
</td>
</tr>
<tr>
<td width="165" valign="top">
<p><b>Subpart D&mdash;Document   Controls</b></p>
</td>
<td width="229" valign="top">
<p>Clause   4. Quality Management System</p>
</td>
<td valign="top">
<p>Differences   addressed in 820.35</p>
</td>
</tr>
<tr>
<td width="165" valign="top">
<p><b>Subpart M&mdash;Records</b></p>
</td>
<td width="229" valign="top">
<p>Clause 4. Quality Management System</p>
</td>
<td valign="top">
<p>Differences addressed in 820.35</p>
</td>
</tr>
<tr>
<td width="165" valign="top">
<p><b>Subpart K&mdash;Labeling   and Packaging Control</b></p>
</td>
<td width="229" valign="top">
<p>Clause 7. Product   Realization</p>
</td>
<td valign="top">
<p>Differences   addressed in 820.45</p>
</td>
</tr>
<tr>
<td width="165" valign="top">
<p><b>Subpart N&mdash;Servicing</b></p>
</td>
<td width="229" valign="top">
<p>Clause 7. Product Realization</p>
</td>
<td valign="top">
<p>Differences addressed in 820.35</p>
</td>
</tr>
</tbody>
</table>
<p style="text-align: left;"><b>Risk Management</b>. &nbsp;Compared to the current QSR, which only explicitly addresses risk management activities in relation to design validation, the ISO standard has a greater emphasis on risk management activities and risk-based decision-making throughout the quality management system (QMS) processes. &nbsp;Risk management for device manufacturers is the essential systematic practice of identifying, analyzing, evaluating, controlling, and monitoring risk throughout the product lifecycle to ensure that the devices they manufacture are safe and effective.&nbsp; FDA expects the explicit integration of risk management throughout the clauses of ISO 13485 will send a clear message to manufacturers that it is necessary to &ldquo;integrate risk management activities throughout their QMS and across the total product lifecycle.&rdquo;</p>
<p style="text-align: left;" class="Default">On March 2, 2022, FDA hosted a public Device Good Manufacturing Practice Advisory Committee meeting.&nbsp; While most industry stakeholders embraced the agency&rsquo;s proposal, some have complained that the implementation period is too quick, saying that two years, rather than one, is a more appropriate timeframe. &nbsp;Stay tuned for more detailed coverage about industry concerns in our next blog.</p>
<p style="text-align: left;"><b><i>Comments on the proposed rule can be submitted in the Federal Register (</i></b><a target="_blank" href="https://www.federalregister.gov/documents/2022/02/23/2022-03227/medical-devices-quality-system-regulation-amendments"><b><i>Docket No. FDA-2021-N-0507</i></b></a><b><i>) until May 24, 2022, and the proposed rule is expected to be effective one year after finalization.</i></b></p>
<p style="text-align: left;">&nbsp;</p>
<div style="position: absolute; left: -10000px; top: 0px; width: 1px; height: 1px; overflow: hidden; text-align: left;" id="_mcePaste">
<p style="text-indent: .5in;" class="Default">The U.S. Food and Drug Administration (FDA) issued the much-anticipated <a href="https://www.federalregister.gov/documents/2022/02/23/2022-03227/medical-devices-quality-system-regulation-amendments">proposed rule</a> &ldquo;Medical Devices: Quality System Regulation Amendments,&rdquo; which will harmonize the current <span style="color: windowtext; background: white;">Quality System Regulation (</span>QSR; <span style="mso-bidi-font-weight: bold;">21 CFR Part 820) with </span>the international standard specific for medical device quality management systems set by the International Organization for Standardization, ISO 13485:2016. <span style="mso-spacerun: yes;">&nbsp;</span>QSR<span style="mso-bidi-font-weight: bold;"> has been the core regulation for device manufacturing in the United States</span> since its implementation <span style="mso-bidi-font-weight: bold;">over 20 years ago. <span style="mso-spacerun: yes;">&nbsp;</span>Medical device establishments have come to have an increasingly international presence, necessitating significant efforts to comply with different requirements.<span style="mso-spacerun: yes;">&nbsp; </span></span>In order to reduce compliance costs for industry and harmonize <span style="color: #212529; background: white;">domestic and international requirements,</span> FDA first signaled its <a href="https://www.fda.gov/media/123488/download">intent</a> to align <span style="color: windowtext;">its <span style="background: white;">QSR with the </span></span>ISO 13485:2016 <span style="color: windowtext; background: white;">in December 2018, and estimated that a proposed rule would be issued in fall 2019.<span style="mso-spacerun: yes;">&nbsp; </span>After delays likely caused by FDA&rsquo;s shift in priorities to focus on the COVID-19 response, the agency finally published the proposed rule last month. <span style="mso-spacerun: yes;">&nbsp;</span></span><span style="color: windowtext;">The long-awaited and long-delayed proposed rule, if finalized</span>, will rename 21 CFR Part 820 as &ldquo;Quality Management System Regulation&rdquo; (QMSR), and will harmonize the U.S. good manufacturing practices with international standards. <span style="mso-spacerun: yes;">&nbsp;</span>The proposal projects to save medical device establishments hundreds of millions of dollars in compliance costs. <span style="mso-spacerun: yes;">&nbsp;</span><span style="mso-bidi-font-weight: bold;"><o:p></o:p></span></p>
<p style="text-indent: .5in;" class="Default"><span style="mso-bidi-font-weight: bold;"><o:p>&nbsp;</o:p></span></p>
<p style="text-indent: .5in;" class="Default"><span style="mso-bidi-font-weight: bold;">Many expected that FDA would rewrite QSR in order to </span>align the U.S. regulatory framework with the ISO standard.<span style="mso-spacerun: yes;">&nbsp; </span>To the surprise of many, FDA performed a gap analysis and now proposes to incorporate ISO 13485 by reference rather than re-writing the regulation in its entirety. <span style="mso-spacerun: yes;">&nbsp;</span>ISO 13485 was first introduced in 1996, around the same time when FDA significantly revised Part 820, establishing the current QS regulation.<span style="mso-spacerun: yes;">&nbsp; </span>ISO 13485 went through many revisions since its first issuance, <span style="color: windowtext;">and its most current version has become more closely aligned with the requirements in part 820. <span style="mso-spacerun: yes;">&nbsp;</span>Notably, the 2016 updates to ISO 13485 included several requirements mandated by FDA under its QSR, such as document control and records management, particularly as both relate to protecting confidential information.<span style="mso-spacerun: yes;">&nbsp; </span>This alignment, as well as the agency&rsquo;s commitment </span>to global regulatory harmonization of medical device regulatory processes,<span style="color: windowtext;"> prompted FDA to further explore incorporating the Quality Management System (QMS) requirements of ISO 13485:2016 into Part 820. <span style="mso-spacerun: yes;">&nbsp;</span>However, this &ldquo;incorporation by reference&rdquo; approach only applies to the current 2016 version of ISO 13485</span> and <span style="color: windowtext;">&ldquo;[a]ny future revisions to this standard would need to be evaluated&rdquo; before being incorporated. <span style="mso-spacerun: yes;">&nbsp;</span></span><o:p></o:p></p>
<p style="background: white; vertical-align: baseline;" class="MsoNormal"><span style="mso-fareast-font-family: &amp;amp;amp; color: #303735;"><o:p>&nbsp;</o:p></span></p>
<p style="text-indent: .5in; background: white; vertical-align: baseline;" class="MsoNormal"><span style="mso-fareast-font-family: &amp;amp;amp;">As before, the proposed rule will only apply to finished devices, although FDA reiterates that it has the legal authority to apply the quality system requirements to manufacturers of components or parts of finished devices when needed. <span style="mso-spacerun: yes;">&nbsp;</span>The proposed QMSR, a nine-page document, is a &ldquo;gap regulation&rdquo; that is intended to be read in conjunction with ISO 13485. <span style="mso-spacerun: yes;">&nbsp;</span>Specifically, the proposed rule addresses FDA-specific requirements by adding necessary requirements and definitions that are absent from ISO 13485 and removing redundant or inconsistent regulations from Part 820.<span style="mso-spacerun: yes;">&nbsp; </span>For example, the proposed rule removed the term &ldquo;device master record&rdquo; (DMR) because (1) the concept is covered by ISO 13485&rsquo;s Clause 4.2.3 on medical device files (MDF) and (2) under the QSR, the DMR is part of the design history file, which is inconsistent with the ISO standard. <span style="mso-spacerun: yes;">&nbsp;</span>Below are some key sections of the new proposed rule. <o:p></o:p></span></p>
<p class="MsoNormal"><span style="mso-fareast-font-family: &amp;amp;amp; color: #303735;"><o:p>&nbsp;</o:p></span></p>
<p style="background: white; vertical-align: baseline;" class="MsoNormal"><b><span style="mso-fareast-font-family: &amp;amp;amp;">Inspection</span></b><span style="mso-fareast-font-family: &amp;amp;amp;">.<b> <span style="mso-spacerun: yes;">&nbsp;</span></b></span><span style="color: #212529;">The proposed rule does not impact FDA&rsquo;s authority to conduct inspections under section 704 of the Food Drug and Cosmetic Act (&ldquo;FD&amp;C Act&rdquo;) (21 U.S.C. &sect; 374). <span style="mso-spacerun: yes;">&nbsp;</span>However, </span><span style="mso-fareast-font-family: &amp;amp;amp;">FDA intends to replace its current inspection approach for medical devices, the Quality System Inspection Technique (QSIT), with an inspection approach that will be consistent with the requirements of the proposed Part 820 as finalized.<span style="mso-spacerun: yes;">&nbsp; </span>Similar to the current QSIT inspection approach, these inspections would involve the collection of information to support observations noted during the inspection and included on FDA Form 483, as appropriate and necessary. <span style="mso-spacerun: yes;">&nbsp;</span>FDA inspections will not result in the issuance of certificates of conformance to ISO 13485, nor is FDA developing a certification program for ISO 13485 or the revised Part 820. <span style="mso-spacerun: yes;">&nbsp;</span>In addition, manufacturers with a certificate of conformance to ISO 13485 are not exempt from FDA inspections. <span style="mso-spacerun: yes;">&nbsp;</span>Firms will need to participate in the Medical Device Single Audit Program (MDSAP) to avoid routine FDA inspections.<o:p></o:p></span></p>
<p style="background: white; vertical-align: baseline;" class="MsoNormal"><b><span style="mso-fareast-font-family: &amp;amp;amp;"><o:p>&nbsp;</o:p></span></b></p>
<p style="background: white; vertical-align: baseline;" class="MsoNormal"><b><span style="mso-fareast-font-family: &amp;amp;amp;">Supplementary Provisions</span></b><span style="mso-fareast-font-family: &amp;amp;amp;">.<span style="mso-spacerun: yes;">&nbsp; </span>To fill the gap with ISO 13485, the proposed rule seeks to add <br> (1) control of records (proposed section&thinsp;820.35) and (2) device labeling and packaging controls (proposed section&thinsp;820.45) to ensure consistency and alignment with other requirements in the FD&amp;C Act and its implementing regulations. <span style="mso-spacerun: yes;">&nbsp;</span><o:p></o:p></span></p>
<p style="background: white; vertical-align: baseline;" class="MsoNormal"><span style="mso-fareast-font-family: &amp;amp;amp;"><o:p>&nbsp;</o:p></span></p>
<p style="text-indent: .5in; background: white; vertical-align: baseline;" class="MsoNormal"><span style="mso-fareast-font-family: &amp;amp;amp;">For<b> control of records</b>, the agency plans to add the following requirements:<span style="mso-spacerun: yes;">&nbsp; </span><o:p></o:p></span></p>
<p style="text-indent: .5in; background: white; vertical-align: baseline;" class="MsoNormal"><span style="mso-fareast-font-family: &amp;amp;amp;"><o:p>&nbsp;</o:p></span></p>
<p style="margin-left: 1.0in; mso-add-space: auto; text-indent: -.25in; mso-list: l0 level1 lfo1; background: white; vertical-align: baseline;" class="MsoListParagraphCxSpFirst"><!--[if !supportLists]--><span style="font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: #0a0a0a;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt &amp;amp;amp;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="mso-fareast-font-family: &amp;amp;amp;">First, </span><span style="color: #0a0a0a; background: white;">signature and date requirements will be required for records</span> <span style="color: #0a0a0a; background: white;">subject to Clause 4.2.5 of ISO 13485 (Control of Records).<span style="mso-spacerun: yes;">&nbsp; </span><o:p></o:p></span></p>
<p style="margin-left: 1.0in; mso-add-space: auto; text-indent: -.25in; mso-list: l0 level1 lfo1; background: white; vertical-align: baseline;" class="MsoListParagraphCxSpMiddle"><!--[if !supportLists]--><span style="font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: #0a0a0a;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt &amp;amp;amp;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="color: #0a0a0a; background: white;">Second, information required by Part 803 (Medical Device Reporting) must be captured on certain records of complaints and servicing activities.<span style="mso-spacerun: yes;">&nbsp; </span><o:p></o:p></span></p>
<p style="margin-left: 1.0in; mso-add-space: auto; text-indent: -.25in; mso-list: l0 level1 lfo1; background: white; vertical-align: baseline;" class="MsoListParagraphCxSpMiddle"><!--[if !supportLists]--><span style="font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: #0a0a0a;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt &amp;amp;amp;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="color: #0a0a0a; background: white;">Third, firms need to document in their records the Unique Device Identification (UDI) for each medical device or batch of medical devices in accordance with Part 830.<span style="mso-spacerun: yes;">&nbsp; </span><o:p></o:p></span></p>
<p style="margin-left: 1.0in; mso-add-space: auto; text-indent: -.25in; mso-list: l0 level1 lfo1; background: white; vertical-align: baseline;" class="MsoListParagraphCxSpLast"><!--[if !supportLists]--><span style="font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: #0a0a0a;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt &amp;amp;amp;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="color: #0a0a0a; background: white;">Fourth, FDA proposes to retain the clarification from current Part 820 (section 820.180) about confidentiality of records FDA receives to remind firms that FDA protects such records in accordance with Part 20.<o:p></o:p></span></p>
<p style="background: white;" class="MsoNormal"><span style="color: #0a0a0a; background: white;"><o:p>&nbsp;</o:p></span></p>
<p style="text-indent: .5in; background: white;" class="MsoNormal"><span style="color: #0a0a0a; background: white;">For<b> device labeling and packaging</b>, </span><span style="color: #212529;">ISO 13485 only states that &ldquo;defined operations for labeling and packaging shall be implemented&rdquo; without specifically addressing the inspection of labeling by the manufacturer. <span style="mso-spacerun: yes;">&nbsp;</span>G</span><span style="color: #0a0a0a; background: white;">iven that many device recalls are related to labeling and packaging,</span><span style="color: #212529;"> </span><span style="color: #0a0a0a; background: white;">FDA proposes to supplement the ISO standard by retaining requirements from the current Part 820 (i.e., Subpart K). <span style="mso-spacerun: yes;">&nbsp;</span>If finalized, regulated industry must meet the requirements in ISO 13485 7.5.1</span> (<span style="color: #0a0a0a; background: white;">Control of Production and Service) and the proposed section&thinsp;820.45.</span><span style="color: #212529;"><o:p></o:p></span></p>
<p style="background: white;" class="MsoNormal"><span style="font-size: 10.0pt; background: white;"><o:p>&nbsp;</o:p></span></p>
<p style="text-align: center; background: white;" align="center" class="MsoNormal"><b><span style="font-size: 10.0pt; background: white;">Table 1&mdash;High-Level Summary of 21 CFR Part 820 Proposed Rule Differences and Additions<o:p></o:p></span></b></p>
<div align="center">
<table style="border-collapse: collapse; border: none; mso-border-alt: solid #BFBFBF .5pt; mso-border-themecolor: background1; mso-border-themeshade: 191; mso-yfti-tbllook: 1184; mso-padding-alt: 0in 5.4pt 0in 5.4pt;" cellpadding="0" cellspacing="0" border="1" class="MsoTable15Plain1">
<tbody>
<tr style="mso-yfti-irow: -1; mso-yfti-firstrow: yes; mso-yfti-lastfirstrow: yes;">
<td style="width: 128.25pt; border: solid #BFBFBF 1.0pt; mso-border-themecolor: background1; mso-border-themeshade: 191; mso-border-alt: solid #BFBFBF .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="165">
<p style="mso-yfti-cnfc: 5;" class="MsoNormal"><b><span style="font-size: 10.0pt; mso-fareast-font-family: &amp;amp;amp; color: #333333;">Current part 820&thinsp;<o:p></o:p></span></b></p>
</td>
<td style="width: 178.5pt; border: solid #BFBFBF 1.0pt; mso-border-themecolor: background1; mso-border-themeshade: 191; border-left: none; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-themecolor: background1; mso-border-left-themeshade: 191; mso-border-alt: solid #BFBFBF .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="229">
<p style="mso-yfti-cnfc: 1;" class="MsoNormal"><b><span style="font-size: 10.0pt; mso-fareast-font-family: &amp;amp;amp; color: #333333;">ISO 13485 requirements&thinsp;<o:p></o:p></span></b></p>
</td>
<td style="border: solid #BFBFBF 1.0pt; mso-border-themecolor: background1; mso-border-themeshade: 191; border-left: none; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-themecolor: background1; mso-border-left-themeshade: 191; mso-border-alt: solid #BFBFBF .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top">
<p style="mso-yfti-cnfc: 1;" class="MsoNormal"><b><span style="font-size: 10.0pt; mso-fareast-font-family: &amp;amp;amp; color: #333333;">Proposed rule<o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 0;">
<td style="width: 128.25pt; border: solid #BFBFBF 1.0pt; mso-border-themecolor: background1; mso-border-themeshade: 191; border-top: none; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-themecolor: background1; mso-border-top-themeshade: 191; mso-border-alt: solid #BFBFBF .5pt; background: #F2F2F2; mso-background-themecolor: background1; mso-background-themeshade: 242; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="165">
<p style="mso-yfti-cnfc: 68;" class="MsoNormal"><b><span style="font-size: 10.0pt; mso-fareast-font-family: &amp;amp;amp; color: #333333;">Subpart D&mdash;Document   Controls<o:p></o:p></span></b></p>
</td>
<td style="width: 178.5pt; border-top: none; border-left: none; border-bottom: solid #BFBFBF 1.0pt; mso-border-bottom-themecolor: background1; mso-border-bottom-themeshade: 191; border-right: solid #BFBFBF 1.0pt; mso-border-right-themecolor: background1; mso-border-right-themeshade: 191; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-themecolor: background1; mso-border-top-themeshade: 191; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-themecolor: background1; mso-border-left-themeshade: 191; mso-border-alt: solid #BFBFBF .5pt; mso-border-themecolor: background1; mso-border-themeshade: 191; background: #F2F2F2; mso-background-themecolor: background1; mso-background-themeshade: 242; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="229">
<p style="text-align: justify; mso-yfti-cnfc: 64;" class="MsoNormal"><span style="font-size: 10.0pt; mso-fareast-font-family: &amp;amp;amp; color: #333333;">Clause   4. Quality Management System<o:p></o:p></span></p>
</td>
<td style="border-top: none; border-left: none; border-bottom: solid #BFBFBF 1.0pt; mso-border-bottom-themecolor: background1; mso-border-bottom-themeshade: 191; border-right: solid #BFBFBF 1.0pt; mso-border-right-themecolor: background1; mso-border-right-themeshade: 191; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-themecolor: background1; mso-border-top-themeshade: 191; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-themecolor: background1; mso-border-left-themeshade: 191; mso-border-alt: solid #BFBFBF .5pt; mso-border-themecolor: background1; mso-border-themeshade: 191; background: #F2F2F2; mso-background-themecolor: background1; mso-background-themeshade: 242; padding: 0in 5.4pt 0in 5.4pt;" valign="top">
<p style="mso-yfti-cnfc: 64;" class="MsoNormal"><span style="font-size: 10.0pt; mso-fareast-font-family: &amp;amp;amp; color: #333333;">Differences   addressed in 820.35<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="width: 128.25pt; border: solid #BFBFBF 1.0pt; mso-border-themecolor: background1; mso-border-themeshade: 191; border-top: none; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-themecolor: background1; mso-border-top-themeshade: 191; mso-border-alt: solid #BFBFBF .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="165">
<p style="mso-yfti-cnfc: 4;" class="MsoNormal"><b><span style="font-size: 10.0pt; mso-fareast-font-family: &amp;amp;amp; color: #333333;">Subpart M&mdash;Records<o:p></o:p></span></b></p>
</td>
<td style="width: 178.5pt; border-top: none; border-left: none; border-bottom: solid #BFBFBF 1.0pt; mso-border-bottom-themecolor: background1; mso-border-bottom-themeshade: 191; border-right: solid #BFBFBF 1.0pt; mso-border-right-themecolor: background1; mso-border-right-themeshade: 191; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-themecolor: background1; mso-border-top-themeshade: 191; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-themecolor: background1; mso-border-left-themeshade: 191; mso-border-alt: solid #BFBFBF .5pt; mso-border-themecolor: background1; mso-border-themeshade: 191; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="229">
<p class="MsoNormal"><span style="font-size: 10.0pt; mso-fareast-font-family: &amp;amp;amp; color: #333333;">Clause 4. Quality Management System<o:p></o:p></span></p>
</td>
<td style="border-top: none; border-left: none; border-bottom: solid #BFBFBF 1.0pt; mso-border-bottom-themecolor: background1; mso-border-bottom-themeshade: 191; border-right: solid #BFBFBF 1.0pt; mso-border-right-themecolor: background1; mso-border-right-themeshade: 191; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-themecolor: background1; mso-border-top-themeshade: 191; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-themecolor: background1; mso-border-left-themeshade: 191; mso-border-alt: solid #BFBFBF .5pt; mso-border-themecolor: background1; mso-border-themeshade: 191; padding: 0in 5.4pt 0in 5.4pt;" valign="top">
<p class="MsoNormal"><span style="font-size: 10.0pt; mso-fareast-font-family: &amp;amp;amp; color: #333333;">Differences addressed in 820.35<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2;">
<td style="width: 128.25pt; border: solid #BFBFBF 1.0pt; mso-border-themecolor: background1; mso-border-themeshade: 191; border-top: none; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-themecolor: background1; mso-border-top-themeshade: 191; mso-border-alt: solid #BFBFBF .5pt; background: #F2F2F2; mso-background-themecolor: background1; mso-background-themeshade: 242; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="165">
<p style="mso-yfti-cnfc: 68;" class="MsoNormal"><b><span style="font-size: 10.0pt; mso-fareast-font-family: &amp;amp;amp; color: #333333;">Subpart K&mdash;Labeling   and Packaging Control<o:p></o:p></span></b></p>
</td>
<td style="width: 178.5pt; border-top: none; border-left: none; border-bottom: solid #BFBFBF 1.0pt; mso-border-bottom-themecolor: background1; mso-border-bottom-themeshade: 191; border-right: solid #BFBFBF 1.0pt; mso-border-right-themecolor: background1; mso-border-right-themeshade: 191; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-themecolor: background1; mso-border-top-themeshade: 191; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-themecolor: background1; mso-border-left-themeshade: 191; mso-border-alt: solid #BFBFBF .5pt; mso-border-themecolor: background1; mso-border-themeshade: 191; background: #F2F2F2; mso-background-themecolor: background1; mso-background-themeshade: 242; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="229">
<p style="mso-yfti-cnfc: 64;" class="MsoNormal"><span style="font-size: 10.0pt; mso-fareast-font-family: &amp;amp;amp; color: #333333;">Clause 7. Product   Realization<o:p></o:p></span></p>
</td>
<td style="border-top: none; border-left: none; border-bottom: solid #BFBFBF 1.0pt; mso-border-bottom-themecolor: background1; mso-border-bottom-themeshade: 191; border-right: solid #BFBFBF 1.0pt; mso-border-right-themecolor: background1; mso-border-right-themeshade: 191; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-themecolor: background1; mso-border-top-themeshade: 191; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-themecolor: background1; mso-border-left-themeshade: 191; mso-border-alt: solid #BFBFBF .5pt; mso-border-themecolor: background1; mso-border-themeshade: 191; background: #F2F2F2; mso-background-themecolor: background1; mso-background-themeshade: 242; padding: 0in 5.4pt 0in 5.4pt;" valign="top">
<p style="mso-yfti-cnfc: 64;" class="MsoNormal"><span style="font-size: 10.0pt; mso-fareast-font-family: &amp;amp;amp; color: #333333;">Differences   addressed in 820.45<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 3; mso-yfti-lastrow: yes;">
<td style="width: 128.25pt; border: solid #BFBFBF 1.0pt; mso-border-themecolor: background1; mso-border-themeshade: 191; border-top: none; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-themecolor: background1; mso-border-top-themeshade: 191; mso-border-alt: solid #BFBFBF .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="165">
<p style="mso-yfti-cnfc: 4;" class="MsoNormal"><b><span style="font-size: 10.0pt; mso-fareast-font-family: &amp;amp;amp; color: #333333;">Subpart N&mdash;Servicing<o:p></o:p></span></b></p>
</td>
<td style="width: 178.5pt; border-top: none; border-left: none; border-bottom: solid #BFBFBF 1.0pt; mso-border-bottom-themecolor: background1; mso-border-bottom-themeshade: 191; border-right: solid #BFBFBF 1.0pt; mso-border-right-themecolor: background1; mso-border-right-themeshade: 191; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-themecolor: background1; mso-border-top-themeshade: 191; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-themecolor: background1; mso-border-left-themeshade: 191; mso-border-alt: solid #BFBFBF .5pt; mso-border-themecolor: background1; mso-border-themeshade: 191; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="229">
<p class="MsoNormal"><span style="font-size: 10.0pt; mso-fareast-font-family: &amp;amp;amp; color: #333333;">Clause 7. Product Realization<o:p></o:p></span></p>
</td>
<td style="border-top: none; border-left: none; border-bottom: solid #BFBFBF 1.0pt; mso-border-bottom-themecolor: background1; mso-border-bottom-themeshade: 191; border-right: solid #BFBFBF 1.0pt; mso-border-right-themecolor: background1; mso-border-right-themeshade: 191; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-themecolor: background1; mso-border-top-themeshade: 191; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-themecolor: background1; mso-border-left-themeshade: 191; mso-border-alt: solid #BFBFBF .5pt; mso-border-themecolor: background1; mso-border-themeshade: 191; padding: 0in 5.4pt 0in 5.4pt;" valign="top">
<p class="MsoNormal"><span style="font-size: 10.0pt; mso-fareast-font-family: &amp;amp;amp; color: #333333;">Differences addressed in 820.35<o:p></o:p></span></p>
</td>
</tr>
</tbody>
</table>
</div>
<p style="background: white;" class="MsoNormal"><span style="background: white;"><o:p>&nbsp;</o:p></span></p>
<p style="background: white;" class="MsoNormal"><b><span style="background: white;">Risk Management</span></b><span style="background: white;">. <span style="mso-spacerun: yes;">&nbsp;</span></span>Compared to the current QSR, which only explicitly addresses risk management activities in relation to design validation, the ISO standard has a greater emphasis on risk management activities and risk-based decision-making throughout the quality management system (QMS) processes<span style="background: white;">.</span> <span style="mso-spacerun: yes;">&nbsp;</span><span style="background: white;">Risk management for device manufacturers is the essential systematic practice of identifying, analyzing, evaluating, controlling, and monitoring risk throughout the product lifecycle to ensure that the devices they manufacture are safe and effective.<span style="mso-spacerun: yes;">&nbsp; </span>FDA expects the explicit integration of risk management throughout the clauses of ISO 13485 will send a clear message to manufacturers that it is necessary to &ldquo;integrate risk management activities throughout their QMS and across the total product lifecycle.&rdquo;<o:p></o:p></span></p>
<p style="background: white;" class="MsoNormal"><span style="background: white;"><o:p>&nbsp;</o:p></span></p>
<p style="text-indent: .5in;" class="Default"><span style="background: white;">On March 2, 2022, FDA hosted a public Device Good Manufacturing Practice Advisory Committee meeting.<span style="mso-spacerun: yes;">&nbsp; </span>While most </span><span style="mso-bidi-font-weight: bold;">industry stakeholders </span><span style="background: white;">embraced the agency&rsquo;s proposal</span><span style="mso-bidi-font-weight: bold;">, some have complained that the implementation period is too quick, saying that two years, rather than one, is a more appropriate timeframe. <span style="mso-spacerun: yes;">&nbsp;</span>Stay tuned for more detailed coverage about industry concerns in our next blog. </span><span style="background: white;"><o:p></o:p></span></p>
<p style="text-indent: .5in;" class="Default"><span style="mso-bidi-font-weight: bold;"><o:p>&nbsp;</o:p></span></p>
<p style="background: white;" class="MsoNormal"><b><i style="mso-bidi-font-style: normal;">Comments on the proposed rule can be submitted in the Federal Register (</i></b><a href="https://www.federalregister.gov/documents/2022/02/23/2022-03227/medical-devices-quality-system-regulation-amendments"><b><i style="mso-bidi-font-style: normal;">Docket No. FDA-2021-N-0507</i></b></a><b><i style="mso-bidi-font-style: normal;">) until May 24, 2022, and the proposed rule is expected to be effective one year after finalization.<span style="background: white;"><o:p></o:p></span></i></b></p>
</div>
                        <div class="sharedaddy sd-sharing-enabled">
                            <div class="robots-nocontent sd-block sd-social sd-social-icon sd-sharing">
                                <h3 class="sd-title">Share This</h3>
                                        <div class="sd-content">
                                                <a title="Share on Facebook" class="nc-facebook-circled" href="unsupportedbrowser.html" target="_blank" onclick="javascript:window.open(this.href, '', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=350,width=600');return false;" rel="nofollow">
                                                    <i class="fab fa-facebook-square"></i>
                                                                                                    </a>
                                                <a href="https://www.linkedin.com/shareArticle?mini=true&amp;url=https://lifesciences.mofo.com/topics/quality-management-system-regulation-qmsr--harmonizing-the-quality-system-regulation-qsr-with-iso-134852016.html&amp;title=Quality Management System Regulation (QMSR) â€“ Harmonizing the Quality System Regulation (QSR) with ISO 13485:2016&amp;summary=Jianyuan (Yuan) Hua, FDA Regulatory and Compliance Associate in New York, contributed to the drafting of this post.

The U.S. Food and Drug Administration (FDA) issued the much-anticipated proposed rule Medical Devices: Quality System Regulation Amendments, which will harmonize the current Quality System Regulation (QSR;&amp;source=LinkedIn" onclick="javascript:window.open(this.href, '', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=350,width=600');return false;" rel="nofollow" class="nc-linkedin-circled" target="_blank" title="Share on LinkedIn">
                                                    <i class="fab fa-linkedin"></i>
                                                                                                    </a>
                                                <a href="share_131.html" onclick="javascript:window.open(this.href, '', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=350,width=600');return false;" rel="nofollow" target="_blank" class="nc-twitter-circled" title="Share on Twitter">
                                                    <i class="fab fa-twitter-square"></i>
                                                                                                    </a>
                                                <a href="mailto:recipient@domain.com?subject=MoFo Life Sciences&amp;body=Quality Management System Regulation (QMSR) â€“ Harmonizing the Quality System Regulation (QSR) with ISO 13485:2016 - https://lifesciences.mofo.com/topics/quality-management-system-regulation-qmsr--harmonizing-the-quality-system-regulation-qsr-with-iso-134852016.html" rel="nofollow" class="nc-fa-envelope-square" title="Email this page">
                                                  <i class="fas fa-envelope-square"></i>
                                                </a>
                                                <a href="#" onclick="printPage()" rel="nofollow" class="nc-fa-print" title="Print this page">
                                                  <i class="fas fa-print"></i>
                                                </a>
                                        
                                        </div>
                            </div>
                        </div>
                        <!-- .entry-content -->
                        <footer class="entry-meta">
                            <div class="entry-meta-footer">
                            </div>
                            <!-- end .entry-meta-footer -->
                        </footer>
                        <!-- .entry-meta -->
</div></article>
<!-- #post -->
                </div>
                <!-- #content -->
                <div id="secondary" class="medium-4 large-4 columns widget-area data-equalizer-watch" role="complementary">
                                        



        
  

                                                                                                   
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														                        	                                      
<div class="text-center">
    <img src="https://media2.mofo.com/images/bondoc_brigid_blog_150x150.png" alt>
</div>
<h5 class="text-center">Brigid DeCoursey Bondoc</h5>
<div class="rockwell text-center subheader">
    Of Counsel
</div>






<p class="bio">Brigid is a food, drug, and medical device lawyer who counsels life sciences companies on a wide range of U.S. Food &amp; Drug Administration pre- and post-market regulatory issues.

As a member of our FDA Regulatory practice, Brigid focuses on medical device, digital health, and in vitro diagnostic companies, as well as other companies whose radiation-emitting electronic products are regulated by FDA&rsquo;s Center for Devices<a href="https://www.mofo.com/people/brigid-bondoc.html" target="_blank"> More &rsaquo;</a>


</p>


        
  

                                                                                                   
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																							                        	                                      
<div class="text-center">
    <img src="https://media2.mofo.com/images/park_rachel_blog_150x150.png" alt>
</div>
<h5 class="text-center">Rachel Park</h5>
<div class="rockwell text-center subheader">
    Associate
</div>






<p class="bio">Rachel Park advises life sciences, medical device, pharmaceutical, and biotech clients on FDA and healthcare regulatory matters.

Prior to joining Morrison &amp; Foerster, Rachel was an associate at an international law firm where she counseled clients on FDA and healthcare regulatory matters. She has counseled pharmaceutical and medical device clients on product promotion, Sunshine Act reporting requirements, and internal compliance investigations. Rachel has helped various<a href="https://www.mofo.com/people/rachel-park.html" target="_blank"> More &rsaquo;</a>


</p>




<aside id="black-studio-tinymce-3" class="widget widget_black_studio_tinymce">
    <div class="textwidget">
        <div class="gray-sidebar">
            <h5>Stay Connected </h5>
                                        <a title="Connect via LinkedIn" class="nc-linkedin-circled" href="https://www.linkedin.com/company/morrison-&amp;-foerster-llp" target="_blank">
                        <i class="icon-linkedin-circled footer-icons black85"></i>
                    </a>
                                        <a title="Connect via Twitter" class="nc-twitter-circled" href="https://twitter.com/MoFoLLP" target="_blank">
                        <i class="icon-twitter-circled footer-icons black85"></i>
                    </a>
                                        <a title="Connect via RSS" class="nc-rss" href="rss" target="_blank">
                        <i class="icon-rss footer-icons black85"></i>
                    </a>
                            </div>
    </div>
</aside>
<aside id="search-2" class="widget widget_search">
    <form role="search" method="get" id="searchform" action="/search/">
        <div class="row collapse">
            <div class="medium-12 large-12 columns">
                <input type="text" value name="s" id="s">
                    <div class="search-icon">
                        <i class="icon-search footer-icons pms-7702c"></i>
                    </div>
                    <input type="submit" id="searchsubmit" value="Search" class="search-btn">
                    </div>
</div>
</form>
</aside>
<aside id="categories-2" class="widget widget_categories">
    <h6 class="widget-title">Topics</h6>
            <label class="screen-reader-text" for="cat">Topics</label>
            <select name="cat" id="cat" class="postform">
                <option value="-1">Topics</option>
                                                                                                                                                <option class="level-0" value="1457511">AI + Robotics</option>
                                                                                                <option class="level-0" value="1457521">Agtech</option>
                                                                                                <option class="level-0" value="1457691">Announcements</option>
                                                                                                <option class="level-0" value="1462201">Antitrust</option>
                                                                                                <option class="level-0" value="1457531">Asia</option>
                                                                                                <option class="level-0" value="1468521">Bioinformatics</option>
                                                                                                <option class="level-0" value="1456751">Biotech</option>
                                                                                                <option class="level-0" value="1458171">Blockchain</option>
                                                                                                <option class="level-0" value="1458511">CFIUS</option>
                                                                                                <option class="level-0" value="1462211">COVID-19</option>
                                                                                                <option class="level-0" value="1457541">Corporate + Venture Capital</option>
                                                                                                <option class="level-0" value="1458861">Data Analytics</option>
                                                                                                <option class="level-0" value="1465651">Digital Health</option>
                                                                                                <option class="level-0" value="1458521">Employment</option>
                                                                                                <option class="level-0" value="1457551">European Union</option>
                                                                                                <option class="level-0" value="1459381">FDA</option>
                                                                                                <option class="level-0" value="1457561">Financing</option>
                                                                                                <option class="level-0" value="1459511">Global</option>
                                                                                                <option class="level-0" value="1459951">Healthcare</option>
                                                                                                <option class="level-0" value="1457581">Intellectual Property</option>
                                                                                                <option class="level-0" value="1457591">Licensing + Commercial</option>
                                                                                                <option class="level-0" value="1457601">Litigation</option>
                                                                                                <option class="level-0" value="1459061">Medical Devices + Diagnostics</option>
                                                                                                <option class="level-0" value="1457631">Pharma</option>
                                                                                                <option class="level-0" value="1457641">Privacy + Data Security</option>
                                                                                                <option class="level-0" value="1457651">Product Liability + Class Action</option>
                                                                                                <option class="level-0" value="1465361">Rare Disease</option>
                                                                                                <option class="level-0" value="1459071">Regulatory</option>
                                                                                                <option class="level-0" value="1459521">Startup</option>
                                                                                                <option class="level-0" value="1462611">United Kingdom</option>
                                                                                                <option class="level-0" value="1457671">United States</option>
                                                            </select>
            <script type="text/javascript">
                /* <![CDATA[ */
                (function() {
                var dropdown = document.getElementById( "cat" );
                function onCatChange() {
                if ( dropdown.options[ dropdown.selectedIndex ].value > 0 ) {
                location.href = "/topics/?c=" + dropdown.options[ dropdown.selectedIndex ].value;
                }
                }
                dropdown.onchange = onCatChange;
                })();
                /* ]]> */
            </script>
</aside>
<aside class="widget widget_recent_entries">
    <h6 class="widget-title">Recent Posts</h6>
            <ul>
                                                    <li>
                        <a href="eu-in-vitro-diagnostic-regulation-entered-into-force-part-3-of-3.html">EU: IN VITRO DIAGNOSTIC REGULATION ENTERED INTO FORCE (PART 3 OF 3)</a>
                    </li>
                                                                    <li>
                        <a href="fda-will-once-again-accept-pre-submissions-for-all-in-vitro-diagnostic-tests.html">FDA Will Once Again Accept Pre-Submissions for All In Vitro Diagnostic Tests</a>
                    </li>
                                                                    <li>
                        <a href="eu-in-vitro-diagnostic-regulation-entered-into-force--part-2-of-3.html">EU: IN VITRO DIAGNOSTIC REGULATION ENTERED INTO FORCE  (PART 2 OF 3) </a>
                    </li>
                                                                    <li>
                        <a href="eu-in-vitro-diagnostic-regulation-entered-into-force--part-1-of-3.html">EU: IN VITRO DIAGNOSTIC REGULATION ENTERED INTO FORCE  (PART 1 OF 3) </a>
                    </li>
                                                                    <li>
                        <a href="senators-call-for-report-on-state-of-psychedelic-research.html">Senators Call for Report on State of Psychedelic Research</a>
                    </li>
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            </ul>
</aside>
<aside id="black-studio-tinymce-6" class="widget widget_black_studio_tinymce">
     <style>

address {
  font-style: normal;
  margin-bottom: 14px;
  margin-left: 10px;
}

address .contact  {
  display: block;
  
}

address .email a:hover {
  color: #0078a0;
}

.location, .attorney, .email {
  display: block;

}

address .email a {
color: #5e5f61;
}

.location {
  font-weight: 900;
  font-family: 'Oswald', sans-serif;
  text-transform: uppercase;
}

.contact-title {
  font-family: 'Oswald', sans-serif;
  font-size: .825em;
  background-color: #eeeeee;
  padding: .8em;
  letter-spacing: 2px;
  text-transform: uppercase;
  margin-bottom: 10px;
  display: block;
  font-weight: 900;
}

</style>




</aside>
                </div>
                <!-- #secondary -->
</section>
<!-- end .content-wrap -->
        </div>
        <!-- end .content_container -->
        <div style="display:none;" id="dialog-message" title="Email Disclaimer">
	<p>Unsolicited e-mails and information sent to Morrison &amp; Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison &amp; Foerster. If you are not already a client of Morrison &amp; Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.</p>
</div>
<div class="footer_container">
    <footer class="footer_wrap row" role="contentinfo">
        <div id="footer" class="row" role="contentinfo">
            <div class="columns medium-12 footer-nav-wrapper">
                <div class="footer-nav">
                    <ul>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-terms-of-use">
                            <a target="_blank" href="https://www.mofo.com/about/terms-notices.html">Terms of Use</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-cookies">
                            <a target="_blank" href="https://www.mofo.com/about/cookies.html">Cookies</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-privacy-policy">
                            <a target="_blank" href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-disclaimer">
                            <a target="_blank" href="https://www.mofo.com/special-content/blog-disclaimer/">Disclaimer</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-attorney-advertising">
                            <a target="_blank" href="https://www.mofo.com/about/attorney-advertising.html">Attorney Advertising</a>
                        </li>
                        </ul></div>
                </div>
                <div class="columns medium-12 text-center">
                    <p class="copyright">&copy;1996-2022 Morrison &amp; Foerster LLP. <span class="show-for-small"><br></span>All Rights Reserved.</p>
                </div>
                <div class="medium-2 medium-centered columns">
                                                            <a title="Connect via LinkedIn" class="nc-linkedin" href="https://www.linkedin.com/company/morrison-&amp;-foerster-llp" target="_blank">
                        <i class="icon-linkedin-circled footer-icons pms-7702c"></i>
                    </a>
                                                            <a title="Connect via Twitter" class="nc-twitter" href="https://twitter.com/MoFoLLP" target="_blank">
                        <i class="icon-twitter-circled footer-icons pms-7702c"></i>
                    </a>
                                                            <a title="Connect via RSS" class="nc-rss" href="rss" target="_blank">
                        <i class="icon-rss footer-icons pms-7702c"></i>
                    </a>
                                    </div>
                                            </div>
</footer>
<!-- .row -->
</div>
<!-- end #footer_container -->
<div id="backtotop" class="hvr-fade">
    <span class="genericon genericon-collapse"></span>
</div>
<!-- #backtotop -->

</div>
     <div class="textwidget">
        <div id="subscribe-modal" class="reveal-modal" data-reveal aria-labelledby="subscribe-modal" aria-hidden="true" role="dialog">
            <aside class="widget widget_black_studio_tinymce">
                <div class="textwidget newsletter_subscribe">
                    <div>
                        <h5>Subscribe</h5>
                                <p>Never miss a post from MoFo Life Sciences. Enter your email below to stay up-to-date.</p>
                    </div>
                </div>
                            </aside>
            <p>
                <div class="resultLabel"></div>
                <div class="widget_wysija_cont shortcode_wysija newsletter_subscribe">
                                   <iframe src="https://www2.mofo.com/l/323401/2020-09-03/621wk" width="100%" height="450" type="text/html" frameborder="0" allowTransparency="true" style="border: 0"></iframe>
                                                </div>
                    <a class="close-reveal-modal" onClick="closeSubscriptionModal()" aria-label="Close"></a>
</p></div>
</div>



<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');
  ga('create', 'UA-12456654-15', 'auto');   ga('send', 'pageview');
</script>

<script type="text/javascript"> 
/*<![CDATA[*/ 
(function() { 
var sz = document.createElement('script'); sz.type = 'text/javascript'; sz.async = true; 
sz.src = '//siteimproveanalytics.com/js/siteanalyze_59840.js'; 
var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(sz, s); 
})(); 
/*]]>*/ 
</script>




<script>
  function myFunction() {
    var x = document.getElementById("myTopnav");
    if (x.className === "topnav") {
      x.className += " responsive";
    } else {
      x.className = "topnav";
    }
  }
  </script>
  
  
  <script>
  

function openSubscribeModal() {
console.log('openSubscribeModal')
  var m = document.getElementById('subscribe-modal');
  m.style.visibility = 'visible';
  m.style.display = 'block';
  }
  
  function closeSubscriptionModal() {
    var m = document.getElementById('subscribe-modal');
  m.style.visibility = 'hidden';
  m.style.display = 'none';
  }

  </script>
  

</body>
</html>